The interaction between propranolol and the novel antimigraine agent zolmitriptan (311C90)

Aims Zolmitriptan (Zomig, formerly known as 311C90), a selective 5HT(1B/1D) agonist is under development as an acute oral treatment for migraine. Despite the use of prophylactic medication, such as propranolol, breakthrough attacks often occur in patients. Consequently we investigated the effects of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Peck, Richard W., Seaber, Emma J., Dixon, Ruth, Gillotin, Catherine G., Weatherley, Barry C., Layton, Gary, Posner, John
Formato: Artigo
Idioma:Inglês
Publicado em: 1997
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2042889/
https://ncbi.nlm.nih.gov/pubmed/9431839
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2125.1997.t01-1-00632.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados